NYSE · Healthcare
REVVITY, INC. (RVTY)
As-reported financials and recent SEC filings for REVVITY, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.86B
Net income
$241.2M
Net margin
8.4%
Diluted EPS
$2.07
ROE
3.3%
P/E (TTM)
54.3×
Market cap
$12.61B
Debt / equity
0.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B |
| Gross profit | — | — | — | — | — |
| Operating income | $356.6M | $346.7M | $300.6M | $742.7M | $1.26B |
| Net income | $241.2M | $270.4M | $693.1M | $569.2M | $943.2M |
| Diluted EPS | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
11-K2026-06-23
View on EDGAR →42026-06-17
View on EDGAR →SD2026-06-01
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →10-Q2026-05-12
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →Go deeper on RVTY
Search REVVITY, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.